| Product NDC: | 64067-216 |
| Proprietary Name: | UVADEX |
| Non Proprietary Name: | Methoxsalen |
| Active Ingredient(s): | 20 ug/mL & nbsp; Methoxsalen |
| Administration Route(s): | EXTRACORPOREAL |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64067-216 |
| Labeler Name: | Therakos, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020969 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990225 |
| Package NDC: | 64067-216-01 |
| Package Description: | 12 VIAL, GLASS in 1 CARTON (64067-216-01) > 10 mL in 1 VIAL, GLASS |
| NDC Code | 64067-216-01 |
| Proprietary Name | UVADEX |
| Package Description | 12 VIAL, GLASS in 1 CARTON (64067-216-01) > 10 mL in 1 VIAL, GLASS |
| Product NDC | 64067-216 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methoxsalen |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | EXTRACORPOREAL |
| Start Marketing Date | 19990225 |
| Marketing Category Name | NDA |
| Labeler Name | Therakos, Inc. |
| Substance Name | METHOXSALEN |
| Strength Number | 20 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Photoabsorption [MoA],Photoactivated Radical Generator [EPC],Photosensitizing Activity [PE],Psoralen [EPC],Psoralens [Chemical/Ingredient] |